Post on 02-Feb-2016
description
The final publication of the COMPARZ trial (already accepted by the NEJM)
The final publication of the PISCES trial (revision just submitted to the JCO)
Therapeuticsfinal results of the AXIS trial
TKI-mTORI-TKI or TKI-TKI-mTORI?
selection criteria for immunotherapy and its efficacy post-TKIs
Prognostic criteriavalidation of the Heng’s score
prognostic factors for survival in Sunitinib-treated patients
Translational researchSunitinib Tx and tumor growth
Post Sunitinib
Post cytokines
Does these resultsreally mean something?
Motzer RJ et al. BJC 2013
c.porta@smatteo.pv.it